Politics Why J&J thinks its new psoriasis pill could be one of its biggest drugs Finance News May 16, 2026 Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to… Read More...
Business Trump FDA Commissioner Marty Makary out Finance News May 13, 2026 Food and Drug Administration Commissioner Marty Makary speaks during an announcement at the Department of Health and… Read More...
Politics CVS Health (CVS) earnings Q1 2026 Finance News May 6, 2026 A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026.Jeenah Moon… Read More...
Politics Novo Nordisk (NVO) Q1 2026 earnings: Wegovy sales jump Finance News May 6, 2026 People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen,… Read More...
Politics Pfizer (PFE) earnings Q1 2026 Finance News May 5, 2026 Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News |… Read More...
Politics Supreme Court blocks mail ban on abortion pill mifepristone Finance News May 4, 2026 In this photo illustration, A packet of Mifepristone is seen at Wyoming's last abortion clinic, Wellspring Center… Read More...
Politics Weight loss drugs pose risk to pharma, report finds Finance News May 4, 2026 Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a "bubble effect" as… Read More...
Politics AstraZeneca stock falls after FDA panel votes against new cancer drug Finance News May 1, 2026 Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental… Read More...
Earnings Eli Lilly (LLY) earnings Q1 2026 Finance News Apr 30, 2026 Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year… Read More...
Politics Reality of Trump’s drug pricing to set in over next 18 months Finance News Apr 28, 2026 Novartis' CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a "very difficult… Read More...